Glucose-insulin-potassium for acute myocardial infarction: Continuing controversy over cardioprotection

Circulation

Volumn 117, Issue 19, 2008, Pages 2523-2533

  Kloner, Robert A ^a,b   Nesto, Richard W ^c  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Glucose; Heart failure; Myocardial infarction; Pharmacology

Indexed keywords

CARDIOVASCULAR AGENT; FATTY ACID; GLUCOSE PLUS INSULIN; GLUCOSE PLUS INSULIN PLUS POTASSIUM; INSULIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE CONTROL; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; DRUG MIXTURE; ECG ABNORMALITY; FATTY ACID BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART DEATH; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; LOW DRUG DOSE; LUNG EMBOLISM; NEOPLASM; OXIDATIVE STRESS; POTASSIUM CURRENT; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; THROMBOCYTE AGGREGATION INHIBITION;

CARDIOTONIC AGENTS; DRUG COMBINATIONS; GLUCOSE; HUMANS; INSULIN; MYOCARDIAL INFARCTION; POTASSIUM; TREATMENT OUTCOME;

EID: 43449089513     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.697979     Document Type: Review

References (64)

1. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 Trial. Eur Heart J. 2006;27:2400-2405.
2. Gruberg L. COOL-MI: cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction. In: Medscape Today. Available at: http://www.medscape.com/viewarticle/461777. Accessed April 26, 2007.
3. Kloner RA, Rezkalla SH. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol. 2004;44:276-286.
4. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-446.
5. Zarich SW, Nesto RW. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation. 2007;115:e436-e439.
6. Surawicz B. Evaluation of treatment of acute myocardial infarction with potassium, glucose, and insulin. Prog Cardiovasc Dis. 1968;10:545-560.
7. Maroko PR, Libby P, Sobel BE, Bloor CM, Sybers HD, Shell WE, Covell JW, Braunwald E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation. 1972;45:1160-1175.
8. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL; ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40:1748-1754.
9. Sodi-Pallares D, Testelli M, Fishelder F. Effects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol. 1962;9:166-181.
10. Opie LH. The glucose hypothesis: relation to acute myocardial ischaemia. J Mol Cell Cardiol. 1970;1:107-114.
11. Hendrickson SC, St Louis JD, Abdel-aleem S. Free fatty acid metabolism during myocardial ischemia and reperfusion. Mol Cell Biochem. 1997;166:85-94.
12. Vanoverschelde JL, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol. 1994;267(part 2):H1785-H1794.
13. Rogers WJ, Stanley AW Jr, Breinig JB, Prather JW, McDaniel HG, Moraski RE, Mantle JA, Russell RO Jr, Rackley CE. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J. 1976;92:441-454.
14. Zarich SW. Mechanism by which hyperglycemia plays a role in the setting of acute cardiovascular illness. Rev Cardiovasc Med. 2006;7(suppl 2):S35-S43.
15. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial inflammation and other acute coronary syndromes. Rev Cardiovasc Med. 2006;7(suppl 2):S25-S34.
16. Angelos MG, Murray HM, Gorsline RT, Klawitter PF. Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics. Resuscitation. 2002;55:329-336.
17. Jonassen AK, Sack NM, Mjøs OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191-1198.
18. Zhu P, Lu L, Xu Y, Greyson C, Schwartz GG. Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol. 2000;278:H595-H603.
19. Zhang HX, Zang YM, Huo JH, Liang SJ, Zhang HF, Wang YM, Fan Q, Guo WY, Wang HC, Gao F. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol. 2006;48:306-313.
20. Jonassen AK, Aasum E, Riemersma RA, Mjøs OD, Larsen TS. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther. 2000;14:615-623.
21. Wilson RA, Okada RD, Barlai-Kovach M, Strauss HW. The effect of glucose-insulin-potassium on thallium-201 myocardial redistribution. Int J Nucl Med Biol. 1985;12:97-101.
22. LaDisa JF Jr, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. Am J Physiol Heart Circ Physiol. 2004;287:H601-H607.
23. Lazar H. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg. 1994;9(suppl):474-478.
24. Zhang HF, Fan Q, Qian XX, Lopez BL, Christopher TA, Ma XL, Gao F. Role of insulin in the anti-apoptotic effect of glucose-insulin-potassium in rabbits with acute myocardial ischemia and reperfusion. Apoptosis. 2004;9:777-783.
25. Kambara H, Yoshida A, Kawashita K, Kawai C. Effects of glucose-insulin-potassium infusion on myocardial infarction and myocardial blood flow following experimental coronary artery occlusion. Jpn Circ J. 1981;45:1158-1163.
26. Heng MK, Norris RM, Peter T, Nisbet HD, Singh BN. The effect of glucose-insulin-potassium on experimental myocardial infarction in the dog. Cardiovasc Res. 1978;12:429-435.
27. Bellows SD, Kloner RA. Glucose-insulin-potassium does not reduce myocardial infarct size in an ischemic/reperfusion rabbit model. J Thromb Thrombolysis. 1995;5:25-27.
28. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152-1156.
29. Díaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Covalán R, Isea JE, Romero G; on behalf of the ECLA (Estudios Cardiológicos Latino-amèrica) Collaborative Group. Metabolic modulation of acute myocardial infarction: the ECLA Glucose-Insulin-Potassium pilot study. Circulation. 1998;98:2227-2234.
30. Ceremuzynski L, Budaj A, Czepiel A, Burzykhowski T, Achremczyk P, Smielak-Korombel W, Maciejewicz J, Dziubinska J, Nartowicz E, Kawka-Urbanek T, Piotrowski W, Hanzlik J, Cieslinski A, Kawecka-Jaszcs K, Gressek J, Wrabee K; for the Pol-GIK trial Investigators. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999;13:191-200.
31. Apstein CS, Opie LH. Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value. Cardiovasc Drugs Ther. 1999;13:185-189.
32. Diaz-Araya G, Nettle D, Castro P, Miranda F, Greig D, Campos X, Chiong M, Nazzal C, Corbalan R, Lavandero S. Oxidative stress after reperfusion with primary coronary angioplasty: lack of effect of glucose-insulin-potassium infusion. Crit Care Med. 2002;30:417-421.
33. van der Horst IC, Zijlstra F, van't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gans RO, Bilo HJ; Zwolle Infarct Study Group. Glucose-insulin-potassium infusion in patients with primary angioplasty for acute myocardial infarction: the Glucose-Insulin-Potassium Study: a randomized trial. J Am Coll Cardiol. 2003;42:784-791.
34. Rasoul S, Ottervanger JP, Timmer JR, Svilaas T, Henriques JP, Dambrink JH, van der Horst IC, Zijlstra F. One year outcomes after glucose-insulin- potassium in ST elevation myocardial infarction: the Glucose-Insulin-Potassium Study II. Int J Cardiol. 2007;122:52-55.
35. Castro PF, Larrain G, Baeza R, Corbalan R, Nazzal C, Greig DP, Miranda FP, Perez O, Acevedo M, Marchant E, Olea E, Gonzalez R. Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty. Crit Care Med. 2003;31:2152-2155.
36. Pache J, Kastrati A, Mehilli J, Bollwein H, Ndrepepa G, Schuhlen H, Martinoff S, Seyfarth M, Nekolla S, Dirschinger J, Schwaiger M, Schomig A. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J. 2004;148:e3.
37. Krljanac G, Vasiljevic Z, Radovanovic M, Stankovic G, Milic N, Stefanovic B, Kostic J, Mitrovic P, Radovanovic N, Dragovic M, Marinkovic J, Karadzic A. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients with thrombolytic therapy. Am J Cardiol. 2005;96:1053-1058.
38. Yazici M, Demircan S, Duran K, Yasar E, Acar Z, Sahin M. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization. Am J Cardiol. 2005;96:1517-1520.
39. van der Horst IC, Ottervanger JP, van't Hof AW, Reiffers S, Miedema K, Hoorntje JC, Dambrink JH, Gosselink AT, Nijsten MW, Suryapranata H, de Boer MJ, Zijlstra F. The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]. BMC Med. 2005;3:9.
40. van der Horst IC, De Luca G, Ottervanger JP, de Boer MJ, Hoorntje JC, Suryapranata H, Dambrink JH, Gosselink AT, Zijlstra F, van't Hof AW. ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion. Am Heart J. 2005;149:1135.
41. Timmer JR, Svilaas T, Ottervanger JP, Henriques JPS, Dambrink J-H, Van den Broek SAJ, van der Horst ICC, Zijlstra F. Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II. J Am Coll Cardiol. 2006;47:1730-1731.
42. Diaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, Chrolavicius S, Zhu J, Kazmi K, Liu L, Budaj A, Zubaid M, Avezum A, Ruda M, Yusuf S. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA. 2007;298:2399-2405.
43. Bucciarelli-Ducci C, Bianchi M, De Luca L, Battagliese A, DiRusso C, Proietti P, Vizza CD, Fedele F. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction. Am J Cardiol. 2006;98:1349-1353.
44. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser RC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;164:982-988.
45. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078-3086.
46. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GB, Todaro TG, Mojcik CF, Armstrong PW, Granger CB. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Hear J. 2006;27:1289-1297.
47. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care. 2005;28:2551-2553.
48. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at one year. J Am Coll Cardiol. 1995;26:57-65.
49. Malmberg K; DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
50. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein R, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, Macleod K, Loakso M, Torp-Pedersen C, Waldenstrom A; DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
51. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765-770.
52. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation. 2004;109:849-854.
53. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
54. Van Den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest. 2004;114:1187-1195.
55. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery: controversies and possible solutions. Ann Thorac Surg. 2003;75:S721-S728.
56. Bothe W, Olschewski M, Beyersdorf F, Doenst T. Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg. 2004;78:1650 -1657.
57. Schipke JD, Friebe R, Gams E. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur J Cardiothorac Surg. 2006;29:479-485.
58. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decrease recurrent ischemic events. Circulation. 2004;109:1497-1502.
59. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-150.
60. Lell WA, Nielsen VG, McGiffin DC, Schmidt FE Jr, Kirklin JK, Stanley AW Jr. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg. 2002;73:1246-1251.
61. Dutka DP, Pitt M, Pagano D, Mongillo M, Gathercole D, Bonser RS, Camici PG. Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol. 2006;48:2225-2231.
62. IMMEDIATE Trial Web Site. Available at: http://www.immediatetrial.com/. Accessed July 31, 2007.
63. van der Horst IC, Timmer JR, Ottervanger JP, Bilo HJ, Gans RO, de Boer MJ, Zijlstra F; GIPS Investigators. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin- Potassium Study-2 (GIPS-2). Am Heart J. 2005;149:585-591.
64. Chandhuri A, Miller M, Nesto R, Rosenberg N, Dandona P. Targeting glucose in acute myocardial infarction: has glucose, insulin, and potassium infusion missed the target? Diabetes Care. 2007;30:3026-3028.